Table 1. Assessment of change in CDVA, CST, and IOP from baseline at months 1, 6, and 12 after injection of dexamethasone implant.
Parameter | Baseline values (range) (Snellena) | Month 1 | Month 6 | Month 12 |
---|---|---|---|---|
P-value from baseline | P-value from baseline | P-value from baseline | ||
CDVA (logMAR) | 0.52±0.12 (0.2–0.78) (20/70) | 0.04±0.02 (20/25) | 0.04±0.03 (20/25) | 0.05±0.02 (20/25) |
P<0.001 | P<0.001 | P<0.001 | ||
CST thickness (microns) | 454.2±45.3 (358–587) | 218.32±38.15 | 221±35.2 | 214±43.34 |
P=0.013 | P=0.013 | P=0.0124 | ||
IOPb (mm Hg) | 14.4±4.32 (8–19) | 16.4±4.4 | 14.8±5 | 13.54±4.2 |
P=0.56 | P=0.48 | P=0.6 |
Abbreviations: CDVA, corrected distance visual acuity; CST, central subfield thickness; IOP, intraocular pressure.
Snellen's equivalent is for mean logMAR.
The median IOP at 2 months was 15.2±3.72 mm Hg (P=0.59).